AR2

PhD Student

Pharm. D in 2015, I am now a Ph.D candidate focusing on the development of a nanodrug against breast cancer. Novel drug delivery systems allow current cancer drugs to exhibit greater efficacy and lower toxicity through improved pharmacokinetics and tumor uptake. I thus work on the biopharmaceutical development and characterization of an immunoliposome and test its efficacy in vitro and in vivo compared to standard treatments.

Top Articles

Article 2

Article 2 Diane

Voir l’article
Phone: +33(0)491835509
Marseille 13005
Faculté de Pharmacie